Valeant

Page 6 of 12

Investors in Female Viagra Are Slamming Valeant
Finance

Investors in Female Viagra Are Slamming Valeant

By
March 25, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Bill Ackman Asked for Information in Drug Pricing Probe

By
March 25, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

The Head of a Buffett-Linked Fund Just Resigned Over Its Huge Valeant Stake

By
March 24, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

The Really Big Problem with Valeant’s Billions of Debt

By
March 23, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Here’s Why Valeant May Have Accused Its Former CFO of “Improper Conduct”

By
March 22, 2016
Drug Hearing
Finance

Valeant Infighting Is Getting Nasty

By
March 21, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health

Valeant Is Looking For a New CEO

By
March 21, 2016
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Finance

What Caused Valeant’s Epic 90% Plunge

By Stephen Gandel and Reuters
March 20, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

This Valeant Investor Is In Even Bigger Trouble than Bill Ackman

By
March 18, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant CEO Promises Company Won’t Go Bankrupt in Staff Memo

By
March 18, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

Ackman’s Hedge Fund Faces S&P Downgrade

By
March 17, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Here’s Why Valeant Shares Plummeted Again

By
March 17, 2016
House Oversight Hearing On Prescription Drug Price Increases
Health

Martin Shkreli’s Former Colleague: We Advised Him Against That Infamous Price Hike

By
March 17, 2016
Hedge fund manager Bill Ackman
Finance

Ackman Sells Big Mondelez Stake Amid Major Losses

By
March 16, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Leadership

Valeant to Walgreens: Hey, It’s Not Your Fault After All

By
March 16, 2016

Most Popular